| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/12/2004 | US20040157901 Vision defects; reducing pressure in eyes |
| 08/12/2004 | US20040157898 Antidiabetic agents; hypotensive agents; anticholesterol agents; antilipemic agents; antiinflammatory agents; antiproliferative agents |
| 08/12/2004 | US20040157897 Polymorphs of an epothilone analog |
| 08/12/2004 | US20040157896 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 08/12/2004 | US20040157895 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157887 Antisecretory agents; gastrointestinal agents |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157885 PPAR activators |
| 08/12/2004 | US20040157884 Accurate, long duration, controlled release of opioids at small dosage levels; implants; minimizing tissue trauma |
| 08/12/2004 | US20040157882 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/12/2004 | US20040157881 Function regulator for retinoid relative receptor |
| 08/12/2004 | US20040157880 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 08/12/2004 | US20040157876 Solid dosage forms; melt granulation |
| 08/12/2004 | US20040157875 1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/12/2004 | US20040157873 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 08/12/2004 | US20040157870 for treating or preventing attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder |
| 08/12/2004 | US20040157869 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157867 Pyrimidine phosphorylase as a target for imaging and therapy |
| 08/12/2004 | US20040157866 Amide compounds |
| 08/12/2004 | US20040157864 Compositions and methods for inducing osteogenesis |
| 08/12/2004 | US20040157863 Triazolopyrimidines |
| 08/12/2004 | US20040157862 estrogen agonist/antagonist is (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol; A kit for use by a consumer to treat osteoarthritis, the kit comprising: estrogen agonist/antagonist; COX-2 inhibitor |
| 08/12/2004 | US20040157861 Compositions and methods for inhibiting TGF-beta |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157857 Substituted chroman derivatives |
| 08/12/2004 | US20040157856 Method of stimulating hair growth using benzopyrans |
| 08/12/2004 | US20040157855 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders |
| 08/12/2004 | US20040157854 CCRS antagonists useful for treating aids |
| 08/12/2004 | US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 08/12/2004 | US20040157850 Novel heterocyclic derivatives |
| 08/12/2004 | US20040157848 effective in treating the symptoms arising from outbreaks of HSV infections, as well as methods of eliminating the virus from the body |
| 08/12/2004 | US20040157847 combination therapy with an alpha-2-delta ligand and a phosphodiesterase V (PDEV) inhibitor results in unexpected improvement in the treatment of pain |
| 08/12/2004 | US20040157846 Process for preparing pyrrolotriazine kinase inhibitors |
| 08/12/2004 | US20040157845 Vanilloid receptor ligands and their use in treatments |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157841 inhibition of histone deacetylase; for inhibiting cell proliferation; cancer therapy |
| 08/12/2004 | US20040157840 Rifalazil compositions and therapeutic regimens |
| 08/12/2004 | US20040157839 substituted pyrazolo[1,5-a][1,3,5]triazine compounds; in particular CB1 receptor antagonists |
| 08/12/2004 | US20040157835 selective inhibition of cyclooxygenase-2, anti-inflammatory and analgesic properties, and no side effects of causing ulcer with the treatment dosage |
| 08/12/2004 | US20040157833 leukotriene B4 inhibitor; optically pure R-enantionmer of tofisopam |
| 08/12/2004 | US20040157831 Therapeutic 5-HT ligand compounds |
| 08/12/2004 | US20040157830 Formailide derivatives as beta2-adrenoreceptor agonists |
| 08/12/2004 | US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent |
| 08/12/2004 | US20040157828 Protease inhibitors |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157825 Quinolone carboxylic acid compositions and related methods of treatment |
| 08/12/2004 | US20040157824 for the treatment of cyclooxygenase mediated diseases; treating pain and the signs and symptoms of arthritis |
| 08/12/2004 | US20040157822 Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 08/12/2004 | US20040157821 Sulfate of cephem compound |
| 08/12/2004 | US20040157820 can stably transport oxygen; blood substitute for patients of a rare blood type, patients refusing blood transfusion for religious reasons and animal care |
| 08/12/2004 | US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis |
| 08/12/2004 | US20040157817 Cycloalkenylsulfonamide derivatives |
| 08/12/2004 | US20040157816 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents |
| 08/12/2004 | US20040157815 fluticasone propionate is completely dissolved in a hydrofluoroalkane (HFA) propellant for use in metered dose inhalers |
| 08/12/2004 | US20040157814 6, 7-Oxygenated steroids and uses related thereto |
| 08/12/2004 | US20040157813 Orally administering melatonin before sleep and dehydroepiandrosterone (dhea) and adrenocorticotropic hormone |
| 08/12/2004 | US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/12/2004 | US20040157811 Inhibition of the growth factor dependency of tumor cells |
| 08/12/2004 | US20040157810 Corticosteroid conjugates and uses thereof |
| 08/12/2004 | US20040157809 androgen receptor blocker is flutamide and the insulin sensitizer is metformin; optionally with contraceptive |
| 08/12/2004 | US20040157808 successfully treated by administering an aromatase inhibitor |
| 08/12/2004 | US20040157807 Reducing tetracycline resistance in living cells |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/12/2004 | US20040157805 11,12-Oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders |
| 08/12/2004 | US20040157802 Anti-microbial agents derived from methionine sulfoximine analogues |
| 08/12/2004 | US20040157801 Anti-sickling agents |
| 08/12/2004 | US20040157799 Pharmaceutical uses of bisphosphonates |
| 08/12/2004 | US20040157798 Drug for use in bone grafting |
| 08/12/2004 | US20040157797 poorly water soluble active agent with solubilizing agent crystalline methylated beta -cyclodextrin; active agent is carbamazepine, fenofibrate, oxcarbazepine, or glipizide |
| 08/12/2004 | US20040157796 Concentrated liquid valdecoxib composition |
| 08/12/2004 | US20040157786 Taxol, Taxotere and their analogues, which possess noteworthy antitumour and antileukaemic properties, are especially useful in the treatment of cancers of the ovary, breast or lung |
| 08/12/2004 | US20040157785 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/12/2004 | US20040157784 Opiod tannate compositions |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157773 Farnesyl protein transferase inhibitors for treating cachexia |
| 08/12/2004 | US20040157767 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/12/2004 | US20040157766 Topical pharmaceutical and/or cosmetic dispense systems |
| 08/12/2004 | US20040157741 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157207 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 08/12/2004 | US20040156931 Administration of capsaicinoids |
| 08/12/2004 | US20040156930 A dissolving patch containing antibiotics (penicillin, amoxicillin) or other medicants (amlexanox and licorice (glycyrrhiza) extract) to treat canker sores of the mouth through sustained release of the healing agents |
| 08/12/2004 | US20040156926 astaxanthin, black cohosh, echinacea, and phytosterols, antitumor agents for breast cancer |
| 08/12/2004 | US20040156925 Plant proanthocyanidin extract effective at inhibiting utility |
| 08/12/2004 | US20040156923 Method and nutraceutical composition for mammals |
| 08/12/2004 | US20040156922 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators |
| 08/12/2004 | US20040156917 Novel methods and devices for treating lung dysfunction |